Since motor neuron degeneration is the primary manifestation observed in SMA, our finding that the Bap1/SMN pathway is required in non-neuronal FAPs for the maturation and maintenance of the neuromuscular system sheds light on SMA pathogenesis and provides an additional therapeutic strategy to treat SMA. Here, SMN2 is linked to proximal spinal muscular atrophy.